RNA editing and drug discovery for cancer therapy

Wei-Hsuan Huang1, Chao-Neng Tseng, Jen-Yang Tang

  • 1Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.

Insights

RNA editing regulates gene expression for cell function. Targeting RNA editing with natural products offers a promising therapeutic strategy for diseases and cancers.

Area of Science:

  • Molecular Biology
  • Genetics
  • Pharmacology

Background:

  • RNA editing is crucial for generating RNA and protein diversity, essential for regulating gene expression.
  • Proper RNA editing maintains cellular function and organism development; its dysregulation is linked to diseases and cancers.
  • Natural products targeting RNA editing are underexplored but hold therapeutic potential.

Purpose of the Study:

  • To provide a comprehensive literature overview of RNA editing's biological functions.
  • To explore the role of RNA editing in gene expression, diseases, and cancers.
  • To summarize bioinformatics resources for RNA editing research and discuss natural product-based therapeutic strategies.

Main Methods:

  • Literature review and synthesis of existing research on RNA editing.
  • Analysis of the biological implications of RNA editing in various contexts.
  • Compilation of available bioinformatics tools and databases relevant to RNA editing.

Main Results:

  • RNA editing significantly contributes to transcriptome and proteome complexity.
  • Imbalances in RNA editing are associated with various pathological conditions, including cancer.
  • Natural products represent an emerging area for targeting RNA editing in therapeutic interventions.

Conclusions:

  • RNA editing is a fundamental biological process with significant implications for health and disease.
  • The potential of natural products in modulating RNA editing for therapeutic purposes warrants further investigation.
  • Understanding RNA editing mechanisms and resources is key for developing novel disease treatments.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...